Medically Reviewed CRRT vs Dialysis: Which Kidney Support Does the ICU Choose?
If you or someone you love is on dialysis and has been told to “watch your heart,” that advice carries more clinical weight than most patients realise. Cardiovascular mortality is 10-20 times higher in dialysis patients than in the general population, a number that reflects how deeply CKD and heart disease are biologically connected, not just coincidentally linked. An estimated 40-50% of all deaths in CKD stages 4 and 5 are cardiovascular, compared with only 26% in those with normal kidney function. Most dialysis patients in India are never told they are statistically more likely to die from a heart event than from kidney failure itself. That gap in awareness has real consequences.
In this blog, we cover why the kidney-heart relationship is bidirectional, how kidney failure directly causes heart attacks, what left ventricular hypertrophy means for your long-term risk, and what the evidence supports for reducing that risk.
Key Takeaways:
- Up to 40% of CKD patients who start dialysis already have heart failure; the cardiac damage begins well before dialysis.
- Protein-bound uremic toxins that cause coronary artery damage are poorly removed by standard dialysis techniques.
- Left ventricular hypertrophy reaches a prevalence of 70-80% in kidney failure patients, and is a direct, independent predictor of cardiac death.
Quick Answer: CKD and heart disease are bidirectional; kidney failure causes heart attacks, LVH, and sudden cardiac death through uremic toxins, volume overload, and chronic inflammation, with cardiovascular mortality 10-20 times higher in dialysis patients.
Quick Links
What Is CRRT and How Is It Different from Dialysis?
CRRT is a form of dialysis that involves slower, continuous filtration of blood over 24 hours, primarily used in critically ill patients whose bodies cannot tolerate the rapid fluid shifts of standard intermittent haemodialysis.
- IHD rapidly corrects fluid overload and electrolyte imbalances, but its intermittent nature causes haemodynamic fluctuations that cardiovascularly unstable patients cannot tolerate. CRRT runs the same process continuously at a fraction of the speed.
- CVVH uses convection for fluid removal; CVVHD uses diffusion through the dialysate; and CVVHDF combines both, chosen based on whether the primary need is fluid removal, solute clearance, or both.
- The standard CRRT dose of 20-25 mL/kg/hr provides slower instantaneous clearance than IHD but a higher total weekly solute clearance than even daily IHD [1].
- Randomised clinical trials and meta-analyses comparing CRRT and IHD have failed to demonstrate superiority of either modality for mortality. CRRT is chosen for haemodynamic tolerance, not proven survival advantage.
- CRRT requires sophisticated equipment and continuous anticoagulation, which can be challenging in certain clinical scenarios, and its availability remains concentrated in large private tertiary centres in India.
Next, let’s explore some critical indicators for CRRT and why the ICU chooses CRRT over dialysis.
CRRT Indications: When the ICU Chooses CRRT Over Dialysis
The ICU does not choose between CRRT and dialysis based on which is better; this decision is clinical and driven by patient haemodynamic status, and both are reasonable options for critically ill patients with AKI who can tolerate them.
Here are five CRRT indications that you must know:
1. Haemodynamic Instability
CRRT is the predominant ICU choice when patients cannot tolerate rapid fluid and solute removal by conventional haemodialysis, particularly in septic shock and multi-organ failure cases. Patients on vasopressors or with MAP below 65 mmHg are the clearest candidates for CRRT over standard dialysis.
2. Acute Brain Injury and Raised ICP
Acute brain injury with raised intracranial pressure is a recognised CRRT indication, as the rapid osmotic shifts of IHD worsen cerebral oedema and increase intracranial pressure further. CRRT’s slow solute removal prevents disequilibrium syndrome entirely, making it the default choice in neurological ICU settings.
3. Sepsis and Multi-Organ Failure
In sepsis and multi-organ failure, inflammatory c bytokine release drives multiple organ dysfunction; CRRT removes many of these mediators from circulation, suggesting clinical benefit over IHD in this setting. Sepsis is the most common indication for CRRT in Indian public-sector ICUs.
4. ECMO Support
Indications for CRRT in ECMO patients do not differ from those for standard AKI; fluid overload, AKI, and electrolyte disturbances are the primary drivers, and AKI occurs in the majority of ECMO patients, making CRRT a near-routine companion therapy. CRRT is routinely combined with ECMO in parallel or integrated circuit arrangements in Indian tertiary cardiac ICUs.
5. Drug Poisoning and Intoxication
IHD is generally preferred over CRRT for poisoning when the patient is stable, given its faster clearance, but high-dose CRRT is considered when haemodynamic instability prevents IHD. In India, organophosphate and paracetamol poisoning are common ICU presentations where this distinction directly guides the choice of modality.
Now, let’s understand the CRRT procedure and the critical considerations you must keep in mind during treatment.
The CRRT Procedure: What Happens During Treatment
CRRT is used in 75.2% of ICU visits globally, yet what actually happens during treatment is rarely explained to patients or their families in plain terms [2].
Here is a step-wise overview for the CRRT procedure and the treatment assaociated with it.
Step 1: Getting Vascular Access
KDIGO recommends the right internal jugular vein as the first-choice access site, followed by femoral and subclavian access. A large double-lumen catheter is placed in this vein at the bedside, and the patient remains connected to the CRRT machine continuously thereafter.
Step 2: Blood Moves Through the Circuit
The volume of blood in the CRRT circuit at any one time ranges from 150 mL to 250 mL, depending on the haemofilter size. This blood flow is 100–200 mL per minute, much slower than standard dialysis, which helps keep the patient’s blood pressure stable throughout treatment.
Step 3: Preventing the Circuit from Clotting
Blood contact with the CRRT circuit triggers clotting, so anticoagulation is essential to keep the filter open and maintain the correct treatment dose throughout the session. Regional citrate anticoagulation is now the preferred method; it prevents clotting within the circuit without systemically thinning the patient’s blood, thereby reducing bleeding risk.
Step 4: When the Filter Clots Anyway
Clotting is the most common cause of treatment interruption; one study found only 68% of patients received their full prescribed CRRT dose because of unplanned circuit downtime. Larger catheter size and citrate anticoagulation are the two strongest protective factors against filter clotting. In Indian ICU settings, filter clotting accounts for 33.8% of all CRRT complications.
Step 5: What Nurses Monitor Throughout
Nursing staff monitor for complications continuously, communicating with the clinical team at every change in the patient’s condition during the session. Blood electrolytes, body temperature, and hourly fluid balance are monitored continuously, which is why CRRT can only run safely in an ICU, not on a general ward.
Next, let’s understand the CRRT survival rate and what medical evidence depicts.
CRRT Survival Rate: What the Evidence Actually Shows
CRRT survival rates are widely misunderstood; outcomes depend almost entirely on how sick the patient is, not on which kidney support modality the ICU chooses.
- Understanding CRRT survival rate data requires knowing that AKI as part of multiple organ dysfunction carries ICU mortality ranging from 28% to 90%, and CRRT is the predominant modality used in this population [3]. A patient with one failing organ has very different odds from a patient with four failing organs; CRRT is not the variable that explains the gap.
- Meeting the criteria for dialysis does not automatically mean CRRT is the superior choice; randomised trials and meta-analyses comparing CRRT and IHD have consistently failed to show that either modality is superior for survival. The ICU chooses CRRT because unstable patients cannot physically tolerate standard dialysis, not because CRRT has a proven mortality advantage.
- In septic shock patients, starting CRRT within 16.5 hours of AKI onset was associated with significantly lower ICU mortality; waiting beyond that point measurably worsened outcomes. Speed of initiation, guided by correct CRRT indications, matters far more than which machine is used.
- Sepsis, ARDS, and rising fluid accumulation are the independent predictors of death in patients undergoing the CRRT procedure. Elevated lactate and a high SOFA score independently predict 28-day mortality. When CRRT patients die, it is because of what brought them to the ICU, not because CRRT failed them.
- Patients who had a nephrologist consulted at CRRT initiation had a 53% lower risk of ICU death compared to those managed without one. In Indian ICUs where intensivists often run CRRT without nephrology input, asking for that consultation is one of the most impactful steps a family can request.
CRRT in Indian ICUs: Access, Challenges, and Cost
For families of patients in Indian ICUs, understanding CRRT vs dialysis goes beyond the clinical question; the barriers to CRRT in India include irregular disposable availability, undertrained staff, limited nephrology services, and restricted tertiary care access.
Here is a tabular representation for the factors for CRRT in Indian ICUs:
| Factor | Reality in India |
|---|---|
| Availability | CRRT is scarce in government hospitals, concentrated in large private tertiary centres. |
| Daily cost | The average cost of a CRRT procedure in India is approximately ₹54,500 per day. |
| Disposables | No domestic manufacturing means that imported disposables inflate costs and significantly restrict access. |
| Staffing | Trained dialysis nurses and technicians are insufficient, especially in government ICU settings |
| SLED alternative | SLED runs 8-12 hours at lower cost, evidence-based for haemodynamically unstable patients where CRRT is unaffordable. |
| Decision barrier | Low health literacy delays family decision-making, worsening time-sensitive CRRT initiation outcomes. |
Also read: Vascular Access Care: Protecting Your Dialysis “Lifeline”.
Final Thoughts
Understanding CRRT vs dialysis clearly is one of the most useful things a family can do when a relative is in the ICU with kidney failure. Starting CRRT too late leads to complications from AKI and volume overload, but starting too early may expose patients who did not truly need it to avoidable harm. If your family member is on CRRT, ask the ICU team directly whether a nephrologist has reviewed the prescription, that single step is associated with a 53% reduction in ICU mortality. If CRRT is unavailable or unaffordable at your current facility, ask about SLED; it is an evidence-based alternative for haemodynamically unstable patients available at select Indian hospitals.
At Eskag Sanjeevani Dialysis centres, where nephrology input is part of critical care coordination, the gap between what is prescribed and what is clinically optimal is far narrower than in settings where intensivists manage kidney support without specialist involvement.
References
- Jha, C.M., Dastoor, H.D., Gopalakrishnan, N. and Holt, S.G. (2022). Obstacles to Early Diagnosis and Treatment of Pruritus in Patients with Chronic Kidney Disease: Current Perspectives. International Journal of Nephrology and Renovascular Disease, Volume 15, pp.335–352.
- Cheng AY, Wong LS. Uremic Pruritus: From Diagnosis to Treatment. Diagnostics (Basel). 2022 Apr 28;12(5):1108. doi: 10.3390/diagnostics12051108. PMID: 35626264; PMCID: PMC9140050.
- van Lieshout, T.S., Driehuis, E., Abrahams, A.C., de Ruijter, V., de Lange, S.J., Bonenkamp, A.A., De Vriese, A.S., Vernooij, R.W.M., Kemperman, P.M.J.H., Rustemeyer, T., van Ittersum, F.J., Penne, E.L. and van Jaarsveld, B.C. (2024). Prevalence and Association of Pruritus and its Current Treatment during the First Year of Dialysis. Kidney360, 6(1), pp.95–104.
CRRT is continuous slow-motion dialysis that runs 24 hours a day; standard dialysis runs for 3-4 hours and then stops. CRRT’s slower fluid and solute removal makes it haemodynamically better tolerated in critically ill patients.
CRRT is primarily for haemodynamically unstable ICU patients with unstable blood pressure who cannot tolerate standard dialysis. Other CRRT indications include acute brain injury, severe fluid overload, ECMO support, and unstable drug poisoning cases.
Clinical trials have not demonstrated survival benefits or improvements in kidney recovery with CRRT compared with intermittent dialysis. CRRT is associated with 80% lower odds of dialysis dependence at 90 days compared to IHD, a kidney recovery advantage without a proven mortality benefit.
CRRT runs until the patient tolerates standard dialysis or no longer requires kidney support. Duration depends entirely on illness severity; some recover kidney function within days, others require weeks of continuous support.
The average cost of a CRRT procedure in India is approximately ₹54,500 per day, paid largely out of pocket. Where cost is a barrier, SLED is an evidence-based lower-cost alternative available at select Indian hospitals for haemodynamically unstable patients.